Diphemanil Methylsulfate 62-97-5 | Anticholinergic Pharmaceutical Intermediate Supplier

Diphemanil Methylsulfate: Quaternary Anticholinergic Agent

Diphemanil methylsulfate is a synthetic quaternary ammonium anticholinergic compound that blocks muscarinic acetylcholine receptors. As a quaternary salt, it does not readily cross the blood-brain barrier, limiting its action primarily to peripheral muscarinic receptors. It has been used to reduce gastric secretion and smooth muscle spasticity.

Product Profile

CAS Number 62-97-5
Molecular Formula C21H27NO4S
Appearance White crystalline powder
Therapeutic Category Anticholinergic / Antispasmodic
Storage Store at controlled room temperature

Applications

Diphemanil methylsulfate has been used as an adjunct in the management of peptic ulcer disease to reduce gastric acid secretion and gastrointestinal motility. It has also found application in controlling excessive sweating (hyperhidrosis) due to its peripheral antimuscarinic activity on eccrine sweat glands. The compound is formulated as oral tablets. While largely superseded by newer antisecretory agents such as proton pump inhibitors, it retains relevance in specific markets and as a pharmaceutical intermediate.

Why Source from TCS

TCS supplies diphemanil methylsulfate to pharmaceutical companies across Europe and globally. Flexible order quantities from development samples to commercial volumes. Contact us with your target market and project requirements for a tailored quotation.

FAQ

What information should be included in an inquiry for Diphemanil Methylsulfate 62-97-5?

A useful inquiry normally includes the product name, target application, estimated quantity, destination market, and any specific documentation or packaging requests.

How is Diphemanil Methylsulfate 62-97-5 usually evaluated for sourcing?

This product is positioned for pharmaceutical sourcing discussions covering development, pilot, or commercial demand, subject to the buyer confirming application scope, market, and document requirements.

What documentation and commercial points are commonly reviewed before buying Diphemanil Methylsulfate 62-97-5?

For pharmaceutical API procurement, buyers commonly align on specification review, target market, batch or annual demand, packaging expectations, and the documentation package needed for the project.

Request a Quote

If your team already has a target application, estimated quantity, destination market, or documentation requirements, send those details so the commercial response can be prepared more efficiently.

Contact the Commercial Team

Scroll to Top